Open Nav

Natsar Pharmaceuticals

  • Venu Raman, Natsar Pharmaceuticals

To obtain funding from investors

  • Date:Wednesday, October 17
  • Time:3:30 PM - 3:45 PM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Natsar Pharmaceuticals, Inc. is an applied research and drug development company developing oncology drugs based upon RNA helicases, ubiquitous enzymes involved in all aspects of RNA metabolism. Based upon a novel target, DDX3, Natsar has developed a first-in-class small molecule, RK-33, that represents a completely new method to treat cancer, targeting DNA repair and cellular bioenergetics. Mission Statement Research and Development that creates hope. Natsar is developing innovative therapies that could deliver profound impact in fighting lung, brain & breast cancer, sarcoma, and many other diseases.
  • Company
  • Company HQ City:Ellicott City
  • Company HQ Country:United States
  • Company HQ State:Maryland                  
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :RK-33
  • Development Phase of Primary Product:Pre-Clinical
  • Total Amount Raised to Date, In All Rounds:$1,000,000
Venu Raman
Natsar Pharmaceuticals